HTLV-1 and Compact disc82 indicators were quantified along the section represented for the focus -panel and plotted for the histogram. for 18 h in the current presence of exogenous IFN- (2000 IU/ml). Neglected (white histogram) and IFN- treated IL-4 DCs (light gray histogram) had been stained with antibodies directed against Compact disc11c, DC-SIGN, NRP-1, HLA-DR, CD40 and CD86. Unstained cells had been used as adverse controls (dark graphs). (B) Treated and neglected IL-4 DC through the same bloodstream donor had HMOX1 been co-cultured with mitomycin-treated C91-PL cells for 3 h as well as the percentage of p19gag-positive DCs was evaluated by movement cytometry. Email address details are representative of 3 3rd party tests performed on different donors. T-test was performed to assess statistically significant variations: ns = non significant.(TIF) ppat.1006353.s002.tif (5.1M) GUID:?C4283DCE-EBF8-48D8-A07A-A9FD7DD3CDC8 S3 Fig: Treatment of UR 1102 IL-4 DCs with supernatant from LPS-matured DCs will not change IL-4 DC phenotype. (A) IL-4 DCs from same donor had been cultured for 18 h with LPS (dark dotted range) or with supernatant from LPS-matured DCs (light gray histogram) or remaining untreated like a control (dark range). Cells had been tagged with antibodies against Compact disc11c, DC-SIGN, NRP-1, HLA-DR, Compact disc86 and Compact disc40. Unstained cells had been used as adverse controls (dark gray histogram). (B and C) IL-4 DCs, IL-4 DCs activated with supernatant from LPS-treated IL-4 DCs and LPS-treated IL-4 DCs through the same donor had been co-cultured with mitomycin-treated C91-PL cells for 3 h (C) or 3 times (B) and the amount of Tax-positive DCs (B) or the percentage of p19gag-positive DCs (C) had been evaluated by movement cytometry. DCs had been discriminated through the C91-PL inhabitants by gating on Compact disc11c manifestation. The email address UR 1102 details are demonstrated as amount of Tax-positive DCs (B) or as percentage of p19gag-positive DCs (C).(TIF) ppat.1006353.s003.tif (9.1M) GUID:?3F2E88AF-3ECB-4F7C-9959-A6F4DA6659B9 S4 Fig: Phenotype of IL-4 DCs treated with TLR agonists. (A) IL-4 DCs had been left neglected (white histogram) or had been treated for 18 h using the TLR-3 ligand PolyI:C, the TLR-4 ligand LPS, the TLR-7/8 ligand R848, the TLR-2 ligand PAM3CSK4 or the TLR-5 ligand flagellin (light gray histogram). Cells had been tagged with antibodies against HLA-DR, Compact disc86 and Compact disc40. Unstained cells had been used as adverse control (dark gray histogram). (B) Supernatant from neglected IL-4 DC or DC treated using the TLR agonists had been gathered after 18 h of tradition and type I IFN amounts assessed using HL116 reporter cells expressing ISRE-Luc.(TIF) ppat.1006353.s004.tif (11M) GUID:?42A8ED42-37A1-4394-A9DC-C970FAF95F85 S5 Fig: HTLV-1 isn’t localized in EE1A+ vesicles after capture by DCs. IL-4 DCs, LPS-treated IL-4 IFN- and DCs DCs had been co-cultured with mitomycin-treated C91-PL cells for 3 h, and immunostained for p19Gag (reddish colored) and EE1A (green) before evaluation by confocal microscopy. Nuclei had been counterstained with DAPI (blue). Representative pictures acquired by confocal microscopy are demonstrated. Scale pubs = 10 m.(TIF) ppat.1006353.s005.tif (3.2M) GUID:?FCC528EA-E319-4077-ABA9-B5B2C61E2FAF S6 Fig: Treatment with entry inhibitors will not affect cell viability. IL-4 DCs (dark pubs), LPS treated IL-4 DCs (light grey pubs) or IFN- DCs (white pubs) had been treated for 3 h with (A) dynamin II inhibitors (dynasore, Dyna), clathrin-mediated endocytosis inhibitors (chlorpromazine, CPZ), actin polymerization inhibitors (latrunculin, lat) or macropinocytosis inhibitors (amiloride, ami) or (B) with constitutive macropinocytosis inhibitors (genistein, Gen), PI3K inhibitor (wortmanin, Wort), PKC inhibitors (rottlerin, G and Rott?6976), Rac-1 inhibitors (NSC23766, NSC), Pak-1 UR 1102 inhibitor (IPA-3, IPA), and actin inhibitor (Cytochalasin D, Cyto D). Cell viability was supervised by FACS using live-dead staining. (C) IL-4 DCs had been left neglected (left -panel) or treated (correct -panel) for 3 h with methyl B cyclodextrine (MCD), set and incubated for 15 min with Nile reddish colored to stain lipid droplets (green). Nuclei had been counterstained with DAPI (blue). Cells had been visualized by fluorescence microscopy. (D-E) IL-4 DCs (dark pubs) or LPS treated IL-4 DCs (light grey bars) had been treated for 3 h with nystatin or MCD to deplete cholesterol (D) or nocodazole (Noco) or blebstatin (bleb) to stop microtubule polymerization (E). After treatment,.